Newsroom

LIMOGES, France--(BUSINESS WIRE)--Regulatory News: Legrand (Paris:LR): Aggregated presentation by day and by market   Name of the issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares* Market (MIC Code) LEGRAND SA 969500XXRPGD7HCAFA90 1-Dec-25 FR0010307819 30 835 128,9506 XPAR LEGRAND SA 969500XXRPGD7HCAFA90 2-Dec-25 FR0010307819 26 213 128,9530 XPAR LEGRAND...

LYON, France--(BUSINESS WIRE)--Regulatory News: MaaT Pharma (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET)1 visant à améliorer la survie des patients atteints de cancers grâce à la modulation du système immunitaire, annonce aujourd’hui que le docteur Florent Malard, PhD et professeur d’hématologie à l’Hôpital Saint-Antoine et à Sorbonne Université, et investigateur principal de l’ess...

LIMOGES, France--(BUSINESS WIRE)--Regulatory News: Legrand (Paris:LR) : Présentation agrégée par jour et par marché   Nom de l'émetteur Code Identifiant de l'émetteur Jour de la transaction Code identifiant de l'instrument financier Volume total journalier (en nombre d'actions) Prix pondéré moyen journalier d'acquisition des actions Marché LEGRAND SA 969500XXRPGD7HCAFA90 1-Dec-25 FR0010307819 30 835 128,9506 XPAR LEGRAND SA 969500XXRPGD7HCAFA90 2-Dec-25 FR0010307819 26 213 128,9530 XPAR LEGRAND...

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS) : Déclaration des transactions sur actions propres Période du 1 au 5 décembre 2025 Emetteur : EMEIS (LEI : 969500LHIH3NT7PK1V89) Catégories de titres : actions ordinaires (ISIN : FR001400NLM4) Descriptif du programme mis en ligne sur le site Internet de l’Autorité des Marchés Financiers le 8 décembre 2025 Rapport hebdomadaire sur les rachats d'actions du 3 novembre au 7 novembre 2025   Nom de l'émetteur Code identifiant de l...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired DeFi Technologies Inc. (“DeFi” or the “Company”) (NASDAQ: DEFT) securities between May 12, 2025 and November 14, 2025, inclusive (the “Class Period”). DeFi investors have until January 30, 2026 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON YOUR D...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming February 2, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) securities between February 6, 2025 and November 16, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BLUE OWL CAPITAL INC. (OWL), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE I...

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 12/8/2025 Issue ¦ Gracechurch Card Programme Funding PLC - Series 14 - 2 Class D GBP 286,793,000 FRN due June 2024     ISIN Number ¦ XS1133034253 ISIN Reference ¦ 113303425 Issue Nomin GBP ¦ 286793000 Period ¦ 11/17/2025 to 12/15/2025   Payment Date 12/15/2025 Number of Days ¦ 28 Rate ¦ 8.9757   Denomination GBP ¦ 1000   ¦ 286793000   ¦       Amount Payable per Denomination ¦ 6.89   ¦ 1974704.17   ¦...

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a leading global consulting and actuarial firm, today announced the acquisition of MorVest Capital, a premier provider of mortgage servicing rights (MSR) analytics, risk management, and advisory services. This strategic move reinforces Milliman’s commitment to delivering comprehensive analytical solutions to the mortgage sector and expands its capabilities with MSR valuation, financing, hedging, and brokering. MorVest Capital, founded in 2013 and headqu...

METAIRIE, La.--(BUSINESS WIRE)--RestorixHealth, the nation’s leading wound care solutions company, has named John Henry Senior Vice President, Growth effective Aug. 27, 2025. In this role, he will lead the company’s Business Development and Marketing Teams. Henry brings to RestorixHealth nearly 30 years of experience in sales and marketing, including over a decade building and scaling brands for various healthcare organizations. He brings a proven track record of developing high-performing sale...

LYON, France--(BUSINESS WIRE)--MaaT Pharma Presents Pivotal ARES Phase 3 Results for MaaT013 in Acute GvHD at ASH 2025 Annual Congress and Announces 54% 1-Year Overall Survival....